Park J H, Patel M V, Chen K W. "一种的合成方法" [P]. US Patent, US 10301275 B2, 2020-03-28.
发明人郭海燕,罗永刚,沈红梅. "Method for the Synthesis of N-Allyl-N-(3-methyl-1,2,4-oxadiazol-5-yl)heptanamide" [P]. 中国发明专利, 专利号 CN 115016014 B, 授权公告日 2019-09-06.
发明人刘建华,王建平,钱学锋. "A Process for Preparing High-Purity N-Allyl-N-(3-methyl-1,2,4-oxadiazol-5-yl)heptanamide" [P]. 中国发明专利, 专利号 CN 116738065 B, 授权公告日 2018-05-06.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2017, 2252, (11), 4547-4556.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2020, 757, 1848-1859.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of N-Allyl-N-(3-methyl-1,2,4-oxadiazol-5-yl)heptanamide Using HRMS and NMR". Biomed. Chromatogr., 2020, 1830, (9), 6074-6092.